Organogenesis Holdings Inc.
ORGO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661181
No open-market purchases or sales by Organogenesis Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $160.4M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Organogenesis Holdings Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 121 | 147 | +26 |
| Shares | 68.4M | 69.5M | +1.13M (+1.7%) |
| Value | $288.5M | $359.8M | +$71.3M (+24.7%) |
New holders (35)
Institutions that held Organogenesis Holdings Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (9)
Institutions that held Organogenesis Holdings Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Cetera Investment Advisers | 52,961 | $223.5K |
| O'Shaughnessy Asset Management, LLC | 14,117 | $59.6K |
| Catalyst Funds Management Pty Ltd | 12,900 | $54.4K |
| Omers Administration Corp | 11,900 | $50.2K |
| Group One Trading, L.P. | 3,800 | $16.0K |
| Advisory Services Network, LLC | 286 | $1.21K |
| Jones Financial Companies LLLP | 255 | $1.05K |
| Financial Consulate, Inc | 60 | $254 |
| Clearstead Advisors, LLC | 13 | $55 |